TBI PLC
7 September 2001
For immediate release
7 September 2001
Not for release, publication or distribution in or into Canada, Australia or
Japan
TBI plc
('TBI' or the 'Company')
POSTING OF DEFENCE DOCUMENT
TBI announces that it will be posting its defence document to TBI Shareholders
today with the Board's unanimous recommendation that Shareholders should
reject the hostile and inadequate offer made for the Company by Vinci.
The Board of TBI firmly believes that:
Vinci's offer significantly undervalues TBI and does not recognise its future
prospects and potential;
TBI has a clear and successful strategy in a rapidly growing industry;
TBI has a portfolio of high quality, valuable assets, both in the UK and
internationally; and
TBI has a proven track record of profitability and growth.
The Board strongly urges TBI Shareholders to follow the Board's example and
reject this bid. The directors and members of their families (and related
trusts), who taken together own 19 per cent. of TBI's issued share capital, do
not intend to accept the bid in respect of their own shareholdings.
G. Stanley Thomas OBE, Chairman of TBI, commented:
'We firmly reject this proposal, which significantly undervalues your company.
Make no mistake, Vinci is trying to get your shares on the cheap. Vinci
realises that the acquisition of your shares at 90p would be fantastic from
their perspective. This bid is entirely opportunistic.
You should not return any form of acceptance in respect of the offer.'
Keith Brooks, Chief Executive of TBI, commented:
'TBI has a clear and successful strategy. We have an attractive portfolio of
assets in a rapidly growing industry.
Our first defence document sets out the fundamentals of our defence; we will
be writing to our shareholders with further detailed information in due
course.'
Enquiries:
TBI 020 7408 7300
Keith Brooks
Caroline Price
Dresdner Kleinwort Wasserstein 020 7623 8000
Charlie Batten
Jeremy Miller
Credit Lyonnais Securities 020 7588 4000
Simon Bennett
ABN AMRO 020 7678 8000
Will Coleman
Buchanan Communications 020 7466 5000
Charles Ryland
Nicola Cronk
The Board accepts responsibility for the information contained in this
announcement. To the best of the knowledge and belief of the Board (which has
taken all reasonable care to ensure that such is the case), the information
contained in this announcement is in accordance with the facts and does not
omit anything likely to affect the import of such information.
Dresdner Kleinwort Wasserstein Limited ('Dresdner Kleinwort Wasserstein') and
Credit Lyonnais Securities, which are regulated by The Securities and Futures
Authority Limited in the United Kingdom, are acting for TBI and no one else in
connection with this matter and will not be responsible to anyone other than
TBI for providing the protections afforded to customers of Dresdner Kleinwort
Wasserstein or Credit Lyonnais Securities nor for providing advice in relation
to this matter.
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.